Novartis
Chagas Disease Patient Experiences in Latin America
Pages
3
Time to read
5 mins
Publication
Language
English
Pages
3
Time to read
5 mins
Publication
Language
English
This report details Chagas disease, a significant public health issue affecting approximately six million individuals in Latin America, where less than 1% receive adequate treatment. The disease is often asymptomatic for years, leading to severe complications, including cardiovascular issues, in many patients. The report highlights the challenges faced by marginalized communities, where the disease is prevalent due to poor living conditions. It includes personal stories from patients like Carmen Cecilia Acuña and Blanca Mayoli Mene, illustrating the impact of Chagas disease on their lives and families. The document also discusses the historical context of the disease, including its discovery by Carlos Chagas, and the ongoing efforts by organizations like the Oswaldo Cruz Foundation and Novartis to address the disease. The establishment of World Chagas Disease Day in 2020 is noted as a significant step toward raising awareness and advocating for necessary resources to combat this neglected tropical disease.